1-241506015-C-G
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_000143.4(FH):āc.892G>Cā(p.Ala298Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,640 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A298G) has been classified as Uncertain significance.
Frequency
Consequence
NM_000143.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FH | NM_000143.4 | c.892G>C | p.Ala298Pro | missense_variant | 6/10 | ENST00000366560.4 | NP_000134.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FH | ENST00000366560.4 | c.892G>C | p.Ala298Pro | missense_variant | 6/10 | 1 | NM_000143.4 | ENSP00000355518.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461640Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727124
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2Uncertain:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 27, 2023 | For these reasons, this variant has been classified as Pathogenic. This sequence change replaces alanine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 298 of the FH protein (p.Ala298Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with hereditary leiomyomatosis and renal cell cancer (HLRCC) (PMID: 22764886; Invitae). ClinVar contains an entry for this variant (Variation ID: 198045). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FH protein function. Experimental studies have shown that this missense change affects FH function (PMID: 22764886). - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 10, 2018 | The A298P variant has been reported previously in association with uterine fibroids and decreased fumarate hydratase activity (Kubinova et al., 2013). The variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The A298P variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties; however, this substitution occurs at a position that is not conserved. A missense variant in a nearby residue (L303S) has been reported in the Human Gene Mutation Database in association with fumarase deficiency (Stenson et al., 2014), supporting the functional importance of this region of the protein. Based on the currently available information, we consider this variant to be likely pathogenic; however, the possibility that it is benign cannot be excluded. - |
Uncertain significance, flagged submission | clinical testing | Eurofins Ntd Llc (ga) | May 28, 2015 | - - |
Hereditary leiomyomatosis and renal cell cancer Pathogenic:1Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Apr 26, 2023 | This variant is considered likely pathogenic. This variant has been reported in multiple individuals with clinical features of gene-specific disease [PMID: 22764886, Myriad internal data]. - |
Uncertain significance, flagged submission | clinical testing | Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia | Jan 17, 2017 | - - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2023 | The p.A298P pathogenic mutation (also known as c.892G>C), located in coding exon 6 of the FH gene, results from a G to C substitution at nucleotide position 892. The alanine at codon 298 is replaced by proline, an amino acid with highly similar properties. This alteration has been observed in multiple individuals with a personal and/or family history that is consistent with FH-related disease (Ambry internal data; Kubinova K et al. J Obstet Gynaecol Res 2013 Jan;39(1):410-4.). This alteration has been shown to segregate with disease in multiple families (Ambry internal data). Additionally, carriers of this alteration were shown to have decreased fumarate hydratase activity in lymphocytes (Kubinova K et al. J Obstet Gynaecol Res 2013 Jan;39(1):410-4.). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at